Pfizer lies behind Mylan’s issues with Epipen

Mylan’s EpiPen is hard to be found in Canada and the UK and in severe shortage in the US. The problem is due to Pfizer, acting as a supplier to Mylan, which is experiencing issues in manufacturing enough product units in the St. Louis (Missouri) plant, operated by the  Meridian Medical Technologies Inc unit (100% Pfizer).